Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure allows for selective modification, making it valuable in developing compounds that modulate protein kinase activity. Commonly employed in medicinal chemistry for constructing pyrazolopyridine-based drug candidates with improved metabolic stability and binding affinity. Also utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug discovery programs.